ACTIVE SURVEILLANCE OF THE SMALL RENAL MASS
Authors:
M. C. Smaldone; D. Canter; J. Simhan; A. Kutikov; R. G. Uzzo *
Authors‘ workplace:
Department of Surgery, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania
*
Published in:
Urol List 2012; 10(1): 26-30
Overview
With the continued, routine use of cross-sectional imaging for unrelated reasons, the incidental diagnosis of small renal masses (< 4 cm) continues to rise. Yet, despite this fact, the overall mortality rate for renal cell carcinoma remains unchanged. Active surveillance of small renal masses has emerged as a viable option for patients, especially those who are older and/or co-morbid. In this article, we review the existing world literature regarding small renal masses with specific interest in growth kinetics and rates of progression/metastases.
Key words:
renal cell carcinoma, small renal mass, active surveillance
Sources
1. Jemal A, Siegel R, Xu J et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60(5): 277–300.
2. Chow WH, Devesa SS, Warren JL et al. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281(17): 1628–1631.
3. Hollingsworth JM, Miller DC, Daignault S et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98(18): 1331–1334.
4. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51(2): 203–205.
5. Crispen PL, Viterbo R, Boorjian SA et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009; 115(13): 2844–2852.
6. Letourneau I, Ouimet D, Dumont M et al. Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol 2003; 23(2): 71–77.
7. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351(13): 1296–1305.
8. Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009; 182(4): 1271–1279.
9. Hollingsworth JM, Miller DC, Daignault S et al. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 2007; 109(9): 1763–1768.
10. Kutikov A, Egleston BL, Wong YN et al. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 2010; 28(2): 311–317.
11. Lane BR, Samplaski MK, Herts BR et al. Renal mass biopsy--a renaissance? J Urol 2008; 179(1): 20–27.
12. Wang R, Wolf JS Jr., Wood DP Jr. et al. Accuracy of percutaneous core biopsy in management of small renal masses. Urology 2009; 73(3): 586–590.
13. Rothman J, Crispen PL, Wong YN et al. Pathologic concordance of sporadic synchronous bilateral renal masses. Urology 2008; 72(1): 138–142.
14. Schachter LR, Bach AM, Snyder ME et al. The impact of tumour location on the histological subtype of renal cortical tumours. BJU Int 2006; 98(1): 63–66.
15. Venkatesh R, Weld K, Ames CD et al. Laparoscopic partial nephrectomy for renal masses: effect of tumor location. Urology 2006; 67(6): 1169–1174.
16. Weizer AZ, Gilbert SM, Roberts WW et al. Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics. J Urol 2008; 180(4): 1273–1278.
17. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182(3): 844–853.
18. Ficarra V, Novara G, Secco S et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 2009; 56(5): 786–793.
19. Simmons MN, Ching CB, Samplaski MK et al. Kidney tumor location measurement using the C index method. J Urol 2010; 183(5): 1708–1713.
20. Kutikov A, Manley BJ, Canter DJ et al. Anatomical features of enhancing renal masses predict histology and grade – an analysis using nephrometry (AUA abstract no. 1238). J Urol 2010; 183(4): e479.
21. Chawla SN, Crispen PL, Hanlon AL et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175(2): 425–431.
22. Smaldone MC, Kutikov A, Canter DJ et al. A Critical Analysis of Active Surveillance with Delayed Curative Intent for the Treatment of Small Renal Masses. Podium presentation (#11); presented at the Society of Urologic Oncology. 2010.
23. Fujimoto N, Sugita A, Terasawa Y et al. Observations on the growth rate of renal cell carcinoma. Int J Urol 1995; 2(2): 71–76.
24. Kato M, Suzuki T, Suzuki Y et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 2004; 172(3): 863–866.
25. Bosniak MA, Birnbaum BA, Krinsky GA et al. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995; 197(3): 589–597.
26. Abou Youssif T, Kassouf W, Steinberg J et al. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 2007; 110(5): 1010–1014.
27. Beisland C, Hjelle KM, Reisaeter LA et al. Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Eur Urol 2009; 55(6): 1419–1427.
28. Fernando HS, Duvuru S, Hawkyard SJ. Conservative management of renal masses in the elderly: our experience. Int Urol Nephrol 2007; 39(1): 203–207.
29. Kouba E, Smith A, McRackan D et al. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 2007; 177(2): 466–470.
30. Lamb GW, Bromwich EJ, Vasey P et al. Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome. Urology 2004; 64(5): 909–913.
31. Matsuzaki M, Kawano Y, Morikawa H et al. Conservative management of small renal tumors. Hinyokika Kiyo 2007; 53(4): 207–211.
32. Siu W, Hafez KS, Johnston WK 3rd et al. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol 2007; 25(2): 115–119.
33. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 2004; 11(5): 2407–2410.
34. Volpe A, Panzarella T, Rendon RA et al. The natural history of incidentally detected small renal masses. Cancer. 2004; 100(4): 738–745.
35. Wehle MJ, Thiel DD, Petrou SP et al. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 2004; 64(1): 49–52.
36. Rosales JC, Haramis G, Moreno J et al. Active surveillance for renal cortical neoplasms. J Urol 2010; 183(5): 1698–1702.
37. Wong JA, Rendon RA. Progression to metastatic disease from a small renal cell carcinoma prospectively followed with an active surveillance protocol. Can Urol Assoc J 2007; 1(2): 120–122.
38. Jewett MA, Finelli A, Morash C et al. Active Surveillance of Small Renal Masses: A Prospective Multi-Center Canadian Uro-Oncology Group Trial: Abstract No. 896. J Urol 2009; 181 (4 Suppl): 320.
39. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol 2008; 180(2): 505–508.
Labels
Paediatric urologist UrologyArticle was published in
Urological Journal
2012 Issue 1
Most read in this issue
- RELATIONSHIPS OF TESTOSTERONE AND PROSTATE CANCER
-
Laparoskopická operace pánevního dna
Část I – laparoskopická kolposuspenze
Část II – laparoskopická kolpopexe - CENTRAL NERVOUS SYSTEM ADVERSE DRUG EVENTS OF ANTIMUSCARINIC MEDICATION
- REPORTING AND GRADING OF COMPLICATIONS AFTER UROLOGIC SURGICAL PROCEDURES: AN AD HOC EAU GUIDELINES PANEL ASSESSMENT AND RECOMMENDATIONS